Modulation of transcriptional responses by poly(I:C) and human rhinovirus: Effect of long-acting β2-adrenoceptor agonists

European Journal of Pharmacology

Volumn 708, Issue 1-3, 2013, Pages 60-67

  Rider, Christopher F ^a   Miller Larsson, Anna ^b   Proud, David ^a   Giembycz, Mark A ^a   Newton, Robert ^a  

^a UNIVERSITY OF CALGARY   (Canada)

^b ASTRAZENECA R AND D   (Sweden)

Author keywords

Asthma; Combination therapy; Corticosteroid resistance; Glucocorticoid resistance; Human rhinovirus; Long acting beta2 adrenoceptor agonist

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 1C; DEXAMETHASONE; DOUBLE STRANDED RNA; FORMOTEROL; GLUCOCORTICOID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 8; POLYINOSINIC POLYCYTIDYLIC ACID; SALMETEROL; TATA BINDING PROTEIN; VIRUS RNA;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; ASTHMA; CDKN1C GENE; CONTROLLED STUDY; CYCLIC AMP RESPONSIVE ELEMENT; DISEASE EXACERBATION; GENE; GENE ACTIVATION; GENE EXPRESSION REGULATION; HORMONE RESPONSIVE ELEMENT; HUMAN; HUMAN CELL; HUMAN RHINOVIRUS; IL8 GENE; INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; RHINOVIRUS INFECTION; SIMIAN VIRUS 40; TRANSCRIPTION REGULATION; VIRUS INDUCTION;

ADRENERGIC BETA-2 RECEPTOR AGONISTS; CELL LINE; CELL LINE, TUMOR; CYCLIC AMP; CYCLIN-DEPENDENT KINASE INHIBITOR P57; DEXAMETHASONE; ETHANOLAMINES; GENES, REPORTER; GLUCOCORTICOIDS; HUMANS; INTERLEUKIN-8; NF-KAPPA B; POLY I-C; RESPONSE ELEMENTS; RHINOVIRUS; TRANSCRIPTION, GENETIC;

EID: 84877807282     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2013.02.056     Document Type: Article

References (58)

1. G.P. Anderson, A. Lindén, and K.F. Rabe Why are long-acting beta-adrenoceptor agonists long-acting? Eur. Respir. J. 7 1994 569 578
2. P.J. Barnes Corticosteroids: the drugs to beat Eur. J. Pharmacol. 533 2006 2 14
3. M. Bergmann, P.J. Barnes, and R. Newton Molecular regulation of granulocyte macrophage colony-stimulating factor in human lung epithelial cells by interleukin (IL)-1β, IL-4, and IL-13 involves both transcriptional and post-transcriptional mechanisms Am. J. Respir. Cell Mol. Biol. 22 2000 582 589
4. J. Bousquet, P.K. Jeffery, W.W. Busse, M. Johnson, and A.M. Vignola Asthma. From bronchoconstriction to airways inflammation and remodeling Am. J. Respir. Crit. Care Med. 161 2000 1720 1745
5. M.A. Cahill, W.H. Ernst, R. Janknecht, and A. Nordheim Regulatory squelching FEBS Lett. 344 1994 105 108
6. M.C. Catley, L.M. Cambridge, Y. Nasuhara, K. Ito, J.E. Chivers, A. Beaton, N.S. Holden, M.W. Bergmann, P.J. Barnes, and R. Newton Inhibitors of protein kinase C (PKC) prevent activated transcription: role of events downstream of NF-κB DNA binding J. Biol. Chem. 279 2004 18457 18466
7. 2-terminal kinase/stress-activated protein kinase J. Biol. Chem. 278 2003 48092 48098
8. J.E. Chivers, W. Gong, E.M. King, J. Seybold, J.C. Mak, L.E. Donnelly, N.S. Holden, and R. Newton Analysis of the dissociated steroid RU24858 does not exclude a role for inducible genes in the anti-inflammatory actions of glucocorticoids Mol. Pharmacol. 70 2006 2084 2095
9. W. De Backer, A. Devolder, G. Poli, D. Acerbi, R. Monno, C. Herpich, K. Sommerer, T. Meyer, and F. Mariotti Lung deposition of BDP/formoterol HFA pMDI in healthy volunteers, asthmatic, and COPD patients J. Aerosol. Med. Pulm. Drug Delivery 23 2010 137 148
10. L. Deszcz, E. Gaudernak, E. Kuechler, and J. Seipelt Apoptotic events induced by human rhinovirus infection J. Gen. Virol. 86 2005 1379 1389
11. F.M. Ducharme, M. Ni Chroinin, I. Greenstone, and T.J. Lasserson Addition of long-acting beta2-agonists to inhaled steroids versus higher dose inhaled steroids in adults and children with persistent asthma Cochrane Database Syst. Rev. 2010 CD005533
12. A. Durham, I.M. Adcock, and O. Tliba Steroid resistance in severe asthma: current mechanisms and future treatment Curr. Pharm. Des. 17 2011 674 684
13. J. Eddleston, J. Herschbach, A.L. Wagelie-Steffen, S.C. Christiansen, and B.L. Zuraw The anti-inflammatory effect of glucocorticoids is mediated by glucocorticoid-induced leucine zipper in epithelial cells J. Allergy Clin. Immunol. 119 2007 115 122
14. J. Eddleston, R.U. Lee, A.M. Doerner, J. Herschbach, and B.L. Zuraw Cigarette smoke decreases the innate responses of epithelial cells to rhinovirus infection Am. J. Respir. Cell Mol. Biol. 44 2010 118 126
15. M.R. Edwards, M.W. Johnson, and S.L. Johnston Combination therapy: synergistic suppression of virus-induced chemokines in airway epithelial cells Am. J. Respir. Cell Mol. Biol. 34 2006 616 624
16. M.R. Edwards, T. Kebadze, M.W. Johnson, and S.L. Johnston New treatment regimes for virus-induced exacerbations of asthma Pulm. Pharmacol. Ther. 19 2006 320 334
17. O. Eickelberg, M. Roth, R. Lorx, V. Bruce, J. Rudiger, M. Johnson, and L.-H. Block Ligand-independent activation of the glucocorticoid receptor by beta 2-adrenergic receptor agonists in primary human lung fibroblasts and vascular smooth muscle cells J. Biol. Chem. 274 1999 1005 1010
18. B.M. Farr, J.M. Gwaltney, J.O. Hendley, F.G. Hayden, R.M. Naclerio, T. McBride, W.J. Doyle, J.V. Sorrentino, D.K. Riker, and D. Proud A randomized controlled trial of glucocorticoid prophylaxis against experimental rhinovirus infection J. Infect. Dis. 162 1990 1173 1177
19. M.A. Giembycz, M. Kaur, R. Leigh, and R. Newton A Holy Grail of asthma management: toward understanding how long-acting beta(2)-adrenoceptor agonists enhance the clinical efficacy of inhaled corticosteroids Br. J. Pharmacol. 153 2008 1090 1104
20. M.A. Giembycz, and R. Newton Beyond the dogma: novel {beta}2-adrenoceptor signalling in the airways Eur. Respir. J. 27 2006 1286 1306
21. K. Grünberg, R.F. Sharon, J.K. Sont, J.C. In 't Veen, W.A. Van Schadewijk, E.P. De Klerk, C.R. Dick, J.H. Van Krieken, and P.J. Sterk Rhinovirus-induced airway inflammation in asthma: effect of treatment with inhaled corticosteroids before and during experimental infection Am. J. Respir. Crit. Care Med. 164 2001 1816 1822
22. K. Grünberg, and P.J. Sterk Rhinovirus infections: induction and modulation of airways inflammation in asthma Clin. Exp. Allergy 29 1999 65 73
23. A. Hinzey, J. Alexander, J. Corry, K.M. Adams, A.M. Claggett, Z.P. Traylor, I.C. Davis, and J.I. Webster Marketon Respiratory syncytial virus represses glucocorticoid receptor-mediated gene activation Endocrinology 152 2011 483 494
24. W. Hoeck, P. Hofer, and B. Groner Overexpression of the glucocorticoid receptor represses transcription from hormone responsive and non-responsive promoters J. Steroid Biochem. Mol. Biol. 41 1992 283 289
25. 2-Adrenoceptor agonist-induced RGS2 expression is a genomic mechanism of bronchoprotection that is enhanced by glucocorticoids Proc. Nat. Acad. Sci. U.S.A. 108 2011 19713 19718
26. N.S. Holden, W. Gong, E.M. King, M. Kaur, M.A. Giembycz, and R. Newton Potentiation of NF-κB-dependent transcription and inflammatory mediator release by histamine in human airway epithelial cells Br. J. Pharmacol. 152 2007 891 902
27. M.H. Hudy, S.L. Traves, S. Wiehler, and D. Proud Cigarette smoke modulates rhinovirus-induced airway epithelial cell chemokine production Eur. Respir. J. 35 2010 1256 1263
28. D.J. Jackson, and S.L. Johnston The role of viruses in acute exacerbations of asthma J. Allergy Clin. Immunol. 125 2010 1178 1187
29. M. Johnson Mechanisms of Action of Beta2-adrenoceptor Agonists 2000 Blackwell Science Ox pp. 1541-1568
30. N.W. Johnston, S.L. Johnston, G.R. Norman, J. Dai, and M.R. Sears The September epidemic of asthma hospitalization: school children as disease vectors J. Allergy Clin. Immunol. 117 2006 557 562
31. M. Kaur, J.E. Chivers, M.A. Giembycz, and R. Newton Long-acting beta2-adrenoceptor agonists synergistically enhance glucocorticoid-dependent transcription in human airway epithelial and smooth muscle cells Mol. Pharmacol. 73 2008 203 214
32. M.M. Kelly, E.M. King, C.F. Rider, C. Gwozd, N.S. Holden, J. Eddleston, B. Zuraw, R. Leigh, P.M. O'Byrne, and R. Newton Corticosteroid-induced gene expression in allergen-challenged asthmatic subjects taking inhaled budesonide Br. J. Pharmacol. 165 2012 1737 1747
33. E.M. King, N.S. Holden, W. Gong, C.F. Rider, and R. Newton Inhibition of NF-kappaB-dependent transcription by MKP-1: transcriptional repression by glucocorticoids occurring via p38 MAPK J. Biol. Chem. 284 2009 26803 26815
34. 2 adrenoceptor independent protein phosphatase 2A activation Pulm. Pharmacol. Ther. 25 2012 201 207
35. H. Lin, J. McGrath, P. Wang, and T. Lee Cellular toxicity induced by SRF-mediated transcriptional squelching Toxicol. Sci. 96 2007 83 91
36. M.E. Meyer, H. Gronemeyer, B. Turcotte, M.T. Bocquel, D. Tasset, and P. Chambon Steroid hormone receptors compete for factors that mediate their enhancer function Cell 57 1989 433 442
37. R. Newton, and N.S. Holden Separating transrepression and transactivation: a distressing divorce for the glucocorticoid receptor? Mol. Pharmacol. 72 2007 799 809
38. R. Newton, R. Leigh, and M.A. Giembycz Pharmacological strategies for improving the efficacy and therapeutic ratio of glucocorticoids in inflammatory lung diseases Pharmacol. Ther. 125 2010 286 327
39. P.M. O'Byrne Therapeutic strategies to reduce asthma exacerbations J. Allergy Clin. Immunol. 128 2011 257 263
40. R.A. Pauwels, C.-G. Lofdahl, D.S. Postma, A.E. Tattersfield, P. O'Byrne, P.J. Barnes, and A. Ullman The formoterol and corticosteroids establishing therapy (FACET) international study group Effect of Inhaled Formoterol and Budesonide on Exacerbations of Asthma. N. Engl. J. Med. 337 1997 1405 1411
41. S.P. Peters Heterogeneity in the pathology and treatment of asthma Am. J. Med. 115 2003 49S 54S
42. A.J. Polito, and D. Proud Epithelia cells as regulators of airway inflammation J. Allergy Clin. Immunol. 102 1998 714 718
43. C.M. Prazma, K.M. Kral, N. Gul, S.W. Yancey, and D.A. Stempel Controller medications and their effects on asthma exacerbations temporally associated with upper respiratory infections Respir. Med. 104 2010 780 787
44. D. Proud Role of rhinovirus infections in asthma Asian Pac. J. Allergy Immunol. 29 2011 201 208
45. D. Proud, and C.-W. Chow Role of viral infections in asthma and chronic obstructive pulmonary disease Am. J. Respir. Cell Mol. Biol. 35 2006 513 518
46. D. Proud, J.M. Gwaltney Jr, J.O. Hendley, C.A. Dinarello, S. Gillis, and R.P. Schleimer Increased levels of interleukin-1 are detected in nasal secretions of volunteers during experimental rhinovirus colds J. Infect. Dis. 169 1994 1007 1013
47. D. Proud, and R. Leigh Epithelial cells and airway diseases Immunol. Rev. 242 2011 186 204
48. D. Proud, S.P. Sanders, and S. Wiehler Human rhinovirus infection induces airway epithelial cell production of human beta-defensin 2 both in vitro and in vivo J. Immunol. 172 2004 4637 4645
49. H.K. Reddel, C. Jenkins, S. Quirce, M.R. Sears, E.D. Bateman, P.M. O'Byrne, M. Humbert, R. Buhl, T. Harrison, G.G. Brusselle, A. Thorén, U. Sjöbring, S. Peterson, O. Ostlund, and G.S. Eriksson Effect of different asthma treatments on risk of cold-related exacerbations Eur. Respir. J. 38 2011 584 593
50. H.K. Reddel, D.R. Taylor, E.D. Bateman, L.-P. Boulet, H.A. Boushey, W.W. Busse, T.B. Casale, P. Chanez, P.L. Enright, P.G. Gibson, J.C. De Jongste, H.A.M. Kerstjens, S.C. Lazarus, M.L. Levy, P.M. O'Byrne, M.R. Partridge, I.D. Pavord, M.R. Sears, P.J. Sterk, S.W. Stoloff, S.D. Sullivan, S.J. Szefler, M.D. Thomas, and S.E. Wenzel On behalf of the American Thoracic Society/European Respiratory Society Task Force on asthma control and exacerbations An Official American Thoracic Society/European Respiratory Society Statement: Asthma Control and Exacerbations: Standardizing Endpoints for Clinical Asthma Trials and Clinical Practice. Am. J. Respir. Crit. Care Med. 180 2009 59 99
51. C.F. Rider, E.M. King, N.S. Holden, M.A. Giembycz, and R. Newton Inflammatory stimuli inhibit glucocorticoid-dependent transactivation in human pulmonary epithelial cells: rescue by long-acting beta2-adrenoceptor agonists J. Pharmacol. Exp. Ther. 338 2011 860 869
52. M. Roth, P.R.A. Johnson, J.J. Rüdiger, G.G. King, Q. Ge, J.K. Burgess, G. Anderson, M. Tamm, and J.L. Black Interaction between glucocorticoids and beta2 agonists on bronchial airway smooth muscle cells through synchronised cellular signalling Lancet 360 2002 1293 1299
53. S.P. Sanders, J. Kim, K. Ryan Connolly, J.D. Porter, E.S. Siekierski, and D. Proud Nitric oxide inhibits rhinovirus-induced granulocyte macrophage colony-stimulating factor production in bronchial epithelial cells Am. J. Respir. Cell Mol. Biol. 24 2001 317 325
54. C.L. Skevaki, I. Christodoulou, I.S. Spyridaki, I. Tiniakou, V. Georgiou, P. Xepapadaki, D.A. Kafetzis, and N.G. Papadopoulos Budesonide and formoterol inhibit inflammatory mediator production by bronchial epithelial cells infected with rhinovirus Clin. Exp. Allergy 39 2009 1700 1710
55. J.C.L. Spurrell, S. Wiehler, R.S. Zaheer, S.P. Sanders, and D. Proud Human airway epithelial cells produce IP-10 (CXCL10) in vitro and in vivo upon rhinovirus infection Am. J. Physiol. Lung Cell Mol. Physiol. 289 2005 L85 L95
56. N.C. Stowell, J. Seideman, H.A. Raymond, K.A. Smalley, R.J. Lamb, D.D. Egenolf, P.J. Bugelski, L.A. Murray, P.A. Marsters, R.A. Bunting, R.A. Flavell, L. Alexopoulou, L.R.S. Mateo, D.E. Griswold, R.T. Sarisky, M.L. Mbow, and A.M. Das Long-term activation of TLR3 by poly(I:C) induces inflammation and impairs lung function in mice Respir. Res. 10 2009 43
57. C.E. Tacon, R. Newton, D. Proud, and R. Leigh Rhinovirus-induced MMP-9 expression is dependent on Fra-1, which is modulated by formoterol and dexamethasone J. Immunol. 188 2012 4621 4630
58. O.S. Usmani, K. Ito, K. Maneechotesuwan, M. Ito, M. Johnson, P.J. Barnes, and I.M. Adcock Glucocorticoid receptor nuclear translocation in airway cells following inhaled combination therapy Am. J. Respir. Crit. Care Med. 2005 200408-1041OC